Biscayne Neurotherapeutics
Latest round
- Series B
Last raised
- Jan 2017
Total raised
- $3M
Investors
- 3
About Biscayne Neurotherapeutics
Biscayne Neurotherapeutics, Inc. specializes in developing innovative neurotherapeutic solutions aimed at improving patient outcomes in neurological disorders.Biscayne Neurotherapeutics, Inc. is involved in the development and commercialization of neurotherapeutic products. In September 2018, Supernus Pharmaceuticals, Inc. agreed to acquire Biscayne Neurotherapeutics, Inc. for up to USD 185 million, which includes a USD 15 million upfront payment, with additional milestones based on development and sales performance. The company operates out of Miami, US, and was founded with a vision of enhancing treatment options for patients with neurological conditions.com is primarily focused on the domain name industry, offering high-value domain names for purchase.com itself, which is marketed at a price of USD 5,495 with an option for a payment plan. The company serves a diverse clientele, ranging from individual entrepreneurs to established businesses seeking to enhance their online presence through unique and memorable web addresses. These domain names are utilized for a variety of purposes, including e-commerce sites, personal branding, and professional services, facilitating easier access for consumers and improving brand visibility.com generates revenue through the sale of its premium domain names, structured to accommodate various purchasing preferences, including outright purchases and installment payment plans.92 per month over a 12-month period, providing flexibility for buyers. This model appeals to a wide array of customers looking to establish a web presence without the burden of upfront costs.com.In September 2018, Supernus Pharmaceuticals, Inc. has agreed to acquire Biscayne Neurotherapeutics, Inc. for up to USD 185 million. The initial payment of USD 15 million will be complemented by USD 75 million in development milestones and up to USD 95 million based on sales performance. The acquisition is expected to close shortly, positioning Biscayne Neurotherapeutics for growth in the neurotherapeutic market.
Who invested in Biscayne Neurotherapeutics
3 investors across 1 round
See all investors in Biscayne Neurotherapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Jan 27, 2017
Amount
$3M
Investors
Questions about Biscayne Neurotherapeutics
Who invested in Biscayne Neurotherapeutics?
Biscayne Neurotherapeutics has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Biscayne Neurotherapeutics raised?
Biscayne Neurotherapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Biscayne Neurotherapeutics last raise money?
Biscayne Neurotherapeutics's most recent round on record is a Series B, in Jan 2017.
What does Biscayne Neurotherapeutics do?
Biscayne Neurotherapeutics, Inc.
Where is Biscayne Neurotherapeutics headquartered?
Biscayne Neurotherapeutics is headquartered in Miami, US.
Which VCs invest in companies like Biscayne Neurotherapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Biscayne Neurotherapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Biscayne Neurotherapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.